Cargando…
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
OBJECTIVE: To evaluate changes in structural damage and joint inflammation assessed by MRI following rituximab treatment in a Phase 3 study of patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) who were naive to biological therapy. METHODS: Patients were randomised to receive...
Autores principales: | Peterfy, Charles, Emery, Paul, Tak, Paul P, Østergaard, Mikkel, DiCarlo, Julie, Otsa, Kati, Navarro Sarabia, Federico, Pavelka, Karel, Bagnard, Marie-Agnes, Gylvin, Lykke Hinsch, Bernasconi, Corrado, Gabriele, Annarita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717395/ https://www.ncbi.nlm.nih.gov/pubmed/25355728 http://dx.doi.org/10.1136/annrheumdis-2014-206015 |
Ejemplares similares
-
Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI
por: Peterfy, Charles G, et al.
Publicado: (2012) -
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
por: Emery, P, et al.
Publicado: (2015) -
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
por: Cohen, Stanley B, et al.
Publicado: (2010) -
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011) -
Psychiatric disease as a risk factor in fast-track hip and knee replacement: An overview of the literature
por: Gylvin, Silas Hinsch, et al.
Publicado: (2016)